Eli Lilly (LLY) director Luciano reports small stock grant

Rhea-AI Filing Summary

ELI LILLY & Co director Juan R. Luciano received a small stock grant. He acquired 17.3030 shares of common stock as a grant or award at a reported price of $919.9000 per share. After this transaction, he directly holds a total of 16,834.7230 Eli Lilly common shares.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider LUCIANO JUAN R

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	17.303	$919.90	$16K

Holdings After Transaction: Common Stock — 16,834.723 shares (Direct, null)

Footnotes (1)

Key Figures

Shares granted: 17.3030 shares Grant valuation price: $919.9000 per share Total shares after transaction: 16,834.7230 shares

3 metrics

Shares granted 17.3030 shares Non-derivative grant/award acquisition of common stock

Grant valuation price $919.9000 per share Reported price for granted Eli Lilly common shares

Total shares after transaction 16,834.7230 shares Director’s direct Eli Lilly common stock holdings after grant

Key Terms

Common Stock, non-derivative, Grant, award, or other acquisition, Form 4

4 terms

Common Stock financial

"security_title: "Common Stock""

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

non-derivative financial

"transaction_type: "non-derivative""

Grant, award, or other acquisition financial

"transaction_code_description: "Grant, award, or other acquisition""

Form 4 regulatory

"INSIDER FILING DATA (Form 4)"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

LUCIANO JUAN R

(Last) (First) (Middle)

LILLY CORPORATE CENTER

(Street)

INDIANAPOLIS INDIANA 46285

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
ELI LILLY & Co [ LLY ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/20/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	04/20/2026		A		17.303	A	$919.9	16,834.723	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

	/s/ Jonathan Groff for Juan R. Luciano, pursuant to authorization on file	04/21/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did LLY director Juan R. Luciano report?

Director Juan R. Luciano reported receiving a small stock grant. He acquired 17.3030 shares of Eli Lilly common stock as a grant or award, rather than an open-market purchase, according to a Form 4 insider filing describing a non-derivative acquisition.

At what price was the Eli Lilly (LLY) stock grant valued?

The reported stock grant to director Juan R. Luciano was valued at $919.9000 per share. This figure reflects the price used in the Form 4 for the 17.3030 common shares received as a grant or award, not necessarily a separate open-market trade.

How many Eli Lilly (LLY) shares does Juan R. Luciano now hold?

After the reported transaction, Juan R. Luciano directly holds 16,834.7230 shares of Eli Lilly common stock. This total includes the newly awarded 17.3030 shares and represents his direct ownership position as disclosed in the Form 4 filing.

Was the LLY insider transaction a purchase or a grant?

The LLY insider transaction was a grant or award, not an open-market purchase. The Form 4 classifies the action with code "A" for "Grant, award, or other acquisition," indicating compensation-related acquisition of 17.3030 common shares rather than a discretionary market buy.

Does the Eli Lilly (LLY) Form 4 show any insider share sales?

The Form 4 excerpt shows no insider share sales for Juan R. Luciano. It reports only one non-derivative acquisition, a grant of 17.3030 common shares, with no corresponding disposition or sale transactions listed in the provided transaction summary data.